Latest News

Keep up-to-date with BMS Canada

• MONTREAL, QUEBEC – March 30, 2012

  CANADIAN DRUG REVIEW PROCESS CONFIRMS CLINICAL BENEFITS OF YERVOY TO TREAT METASTATIC MELANOMA

  BMS is committed to ensuring patients in provinces have access to this life-extending treatment

  Categories: Public Communication | Public Notices | Yervoy

• MONTREAL, QUEBEC – March 29, 2012

  ELIQUIS® (apixaban) Available in Canada for the Prevention of Venous Thromboembolism after Elective Hip or Knee Replacement

  A new oral direct Factor Xa inhibitor

  Categories: Eliquis | Public Communication | Public Notices

• MONTREAL, QUEBEC – February 7, 2012

  First and only treatment to extend survival for people with metastatic melanoma, the most deadly form of skin cancer, approved in canada

  Melanoma one of fastest growing cancers in Canada

  Categories: Public Notices

• News Releases
• Media Room
• RSS Feeds

Community

Events & Programs

BMS Canada is committed to community involvement. Find out more.

• Events and Community News
• Donations
• Partnerships

Careers

Looking for a Great Career?

Bristol-Myers Squibb Canada can offer you the challenge and support you are looking for in a friendly, motivating and exciting atmosphere. Find out more.

• Our Culture
• What's in it for you?
• Join Us